These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9567330)

  • 1. [Cardiac amyloidosis. A disease with many faces and different prognosis].
    Barretto AC; Precoma D; Serro-Azul JB; Wajngarten M; Pierri H; Pivotto L; Nussbacher A; Gebara OC; Bellotti G
    Arq Bras Cardiol; 1997 Aug; 69(2):89-93. PubMed ID: 9567330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac amyloidosis. Invasive and noninvasive diagnosis].
    Pinamonti B; Dreas L; Bussani R; Mestroni L; Silvestri F; Tanganelli P; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1016-30. PubMed ID: 3503797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy complicated with cardiac amyloidosis.
    Kohno I; Komori S; Yamamoto K; Sano S; Ishihara T; Umetani K; Sawanobori T; Ijiri H; Tamura K
    Intern Med; 2000 Aug; 39(8):637-40. PubMed ID: 10939537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia.
    Nojima Y; Ihara M; Kurimoto T; Nanto S
    Am J Case Rep; 2016 Apr; 17():235-40. PubMed ID: 27064109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with cardiac amyloidosis.
    Goeminne A; Missault L; Bauwens F; De Pauw M; De Sutter J
    Acta Cardiol; 2003 Apr; 58(2):143-7. PubMed ID: 12715906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid Cardiomyopathy in the Emergency Department.
    Baca M; Newberry M
    J Emerg Med; 2019 Feb; 56(2):205-209. PubMed ID: 30553561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The rapid progress of heart failure due to systemic amyloidosis with cardiac involvement--case report].
    Gilowski W; Stryjewski P; Gilowska M; Liszniański P; Nowak J
    Przegl Lek; 2015; 72(11):697-700. PubMed ID: 27012134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary restrictive cardiomyopathy: clinical and pathologic characteristics.
    Katritsis D; Wilmshurst PT; Wendon JA; Davies MJ; Webb-Peploe MM
    J Am Coll Cardiol; 1991 Nov; 18(5):1230-5. PubMed ID: 1918700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac amyloidosis: an analysis of five cases].
    Zhang SB; Wang LS; He P
    Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):381-3. PubMed ID: 8269769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic restrictive cardiomyopathy].
    Nacruth R; Barretto AC; Mady C; da Luz PL; Pileggi F
    Arq Bras Cardiol; 1993 Sep; 61(3):175-80. PubMed ID: 8110048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current state of cardiac amyloidosis.
    Sharma N; Howlett J
    Curr Opin Cardiol; 2013 Mar; 28(2):242-8. PubMed ID: 23324855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic heart failure in patients with cardiac amyloidosis].
    Solomakhina NI; Varshavskiĭ VA; Gundarova LV; Golitsina EP; Shchekochikhin DIu
    Klin Med (Mosk); 2009; 87(3):26-30. PubMed ID: 19469251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Idiopathic restrictive cardiomyopathy: clinical, hemodynamic, histologic and prognostic profile].
    Ortolani P; Rapezzi C; Binetti G; Baroni M; Mirri A; Alampi G; Benati A; Branzi A; Magnani B
    Cardiologia; 1989 Sep; 34(9):759-68. PubMed ID: 2605584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary systemic amyloidosis with cardiac manifestations].
    Fischer H; Woitinas F; Morell R; Zwehl W
    Dtsch Med Wochenschr; 1995 Aug; 120(33):1118-22. PubMed ID: 7656836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac amyloidosis: new insights into diagnosis and management.
    Eshaghian S; Kaul S; Shah PK
    Rev Cardiovasc Med; 2007; 8(4):189-99. PubMed ID: 18192942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
    Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
    Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart failure with preserved left ventricular function: clinical, echocardiographic, and clinical course features. Prognostic factors].
    Bounhoure JP; Massabuau P; Galinier M; Jordan C; Laurent JP; Marco J
    Bull Acad Natl Med; 2002; 186(6):1003-13; discussion 1013-4. PubMed ID: 12587339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.